The impact of comorbidities and their stacking on short- and long-term prognosis of patients over 50 with community-acquired pneumonia.

E Blanc, G Chaize, S Fievez, C Féger, E Herquelot, A Vainchtock, J F Timsit, J Gaillat
Author Information
  1. E Blanc: Pfizer, Paris, France.
  2. G Chaize: HEVA, Lyon, France.
  3. S Fievez: Pfizer, Paris, France.
  4. C Féger: EMIBiotech, Paris, France.
  5. E Herquelot: HEVA, Lyon, France.
  6. A Vainchtock: HEVA, Lyon, France.
  7. J F Timsit: Medical and Infectious Diseases ICU, Bichat-Claude Bernard Hospital, APHP, Paris, France.
  8. J Gaillat: Infectious Diseases Department, Annecy-Genevois Hospital, Annecy, France. jgaillat@ch-annecygenevois.fr.

Abstract

BACKGROUND: The prognosis of patients hospitalized with community-acquired pneumonia (CAP) with regards to intensive care unit (ICU) admission, short- and long-term mortality is correlated with patient's comorbidities. For patients hospitalized for CAP, including P-CAP, we assessed the prognostic impact of comorbidities known as at-risk (AR) or high-risk (HR) of pneumococcal CAP (P-CAP), and of the number of combined comorbidities.
METHODS: Data on hospitalizations for CAP among the French 50+ population were extracted from the 2014 French Information Systems Medicalization Program (PMSI), an exhaustive national hospital discharge database maintained by the French Technical Agency of Information on Hospitalization (ATIH). Their admission diagnosis, comorbidities (nature, risk type and number), other characteristics, and their subsequent hospital stays within the year following their hospitalization for CAP were analyzed. Logistic regression models were used to assess the associations between ICU transfer, short- and 1-year in-hospital mortality and all covariates.
RESULTS: From 182,858 patients, 149,555 patients aged ≥ 50 years (nonagenarians 17.8%) were hospitalized for CAP in 2014, including 8270 with P-CAP. Overall, 33.8% and 90.5% had ≥ 1 HR and ≥ 1 AR comorbidity, respectively. Cardiac diseases were the most frequent AR comorbidity (all CAP: 77.4%). Transfer in ICU occurred for 5.4% of CAP patients and 19.4% for P-CAP. Short-term and 1-year in-hospital mortality rates were 10.9% and 23% of CAP patients, respectively, significantly lower for P-CAP patients: 9.2% and 19.8% (HR 0.88 [95% CI 0.84-0.93], p < .0001). Both terms of mortality increased mostly with age, and with the number of comorbidities and combination of AR and HR comorbidities, in addition of specific comorbidities.
CONCLUSIONS: Not only specific comorbidities, but also the number of combined comorbidities and the combination of AR and HR comorbidities may impact the outcome of hospitalized CAP and P-CAP patients.

Keywords

References

  1. Ann Am Thorac Soc. 2016 Sep;13(9):1519-26 [PMID: 27398827]
  2. Curr Opin Infect Dis. 2014 Jun;27(3):295-301 [PMID: 24685550]
  3. Clin Infect Dis. 2017 Nov 13;65(11):1806-1812 [PMID: 29020164]
  4. Epidemiol Infect. 2010 Dec;138(12):1804-10 [PMID: 20429967]
  5. Health Serv Res Manag Epidemiol. 2020 Jul 24;7:2333392820939801 [PMID: 32782916]
  6. Pulmonology. 2020 May - Jun;26(3):123-129 [PMID: 31787563]
  7. Arch Intern Med. 2003 Feb 10;163(3):317-23 [PMID: 12578512]
  8. Ann Intensive Care. 2018 Aug 15;8(1):84 [PMID: 30112650]
  9. Medicine (Baltimore). 2008 Nov;87(6):329-334 [PMID: 19011504]
  10. Eur J Health Econ. 2018 May;19(4):533-544 [PMID: 28547724]
  11. Vaccine. 2015 Jul 17;33(31):3703-8 [PMID: 26073016]
  12. JAMA. 2012 Apr 4;307(13):1405-13 [PMID: 22474204]
  13. Eur Respir Rev. 2020 Feb 19;29(155): [PMID: 32075858]
  14. MMWR Morb Mortal Wkly Rep. 2012 Oct 12;61(40):816-9 [PMID: 23051612]
  15. Am J Med Qual. 2005 Nov-Dec;20(6):319-28 [PMID: 16280395]
  16. Chest. 2018 Sep;154(3):628-635 [PMID: 29859184]
  17. Respir Med. 2018 Apr;137:6-13 [PMID: 29605214]
  18. BMC Public Health. 2012 Aug 30;12:715 [PMID: 22935268]
  19. Aliment Pharmacol Ther. 2019 Jan;49(1):84-90 [PMID: 30485467]
  20. Curr Med Res Opin. 2020 Jan;36(1):151-160 [PMID: 31566005]
  21. Eur J Intern Med. 2017 May;40:64-71 [PMID: 27979670]
  22. Respirology. 2017 May;22(4):778-785 [PMID: 28093834]
  23. Vaccine. 2017 Mar 23;35(13):1692-1697 [PMID: 28245940]
  24. Clin Infect Dis. 2003 Dec 15;37(12):1617-24 [PMID: 14689342]
  25. BMC Infect Dis. 2018 Apr 24;18(1):192 [PMID: 29699493]
  26. Open Forum Infect Dis. 2019 Nov 30;6(12):ofz510 [PMID: 31868865]
  27. PLoS One. 2013;8(4):e60273 [PMID: 23565216]
  28. Eur J Cancer Care (Engl). 2018 Mar;27(2):e12817 [PMID: 29575267]
  29. PLoS One. 2012;7(2):e32190 [PMID: 22393389]
  30. BMC Infect Dis. 2016 Aug 03;16:367 [PMID: 27487784]
  31. J Infect Dis. 2012 May 15;205(10):1589-92 [PMID: 22448012]
  32. BMC Health Serv Res. 2017 Aug 17;17(1):572 [PMID: 28818082]

MeSH Term

Aged
Aged, 80 and over
Community-Acquired Infections
Comorbidity
Hospitalization
Humans
Pneumonia
Prognosis
Retrospective Studies
Risk Factors

Word Cloud

Created with Highcharts 10.0.0comorbiditiesCAPpatientsP-CAPpneumoniamortalityARHRhospitalizednumberICUshort-impactFrench8%4%prognosiscommunity-acquiredadmissionlong-termincludingcombined2014Informationhospital1-yearin-hospitalcomorbidityrespectively190combinationspecificstackingBACKGROUND:regardsintensivecareunitcorrelatedpatient'sassessedprognosticknownat-riskhigh-riskpneumococcalMETHODS:Datahospitalizationsamong50+ populationextractedSystemsMedicalizationProgramPMSIexhaustivenationaldischargedatabasemaintainedTechnicalAgencyHospitalizationATIHdiagnosisnaturerisktypecharacteristicssubsequentstayswithinyearfollowinghospitalizationanalyzedLogisticregressionmodelsusedassessassociationstransfercovariatesRESULTS:182858149555aged ≥ 50 yearsnonagenarians178270Overall33905%had ≥ 1and ≥ 1CardiacdiseasesfrequentCAP:77Transferoccurred5Short-termrates109%23%significantlylowerpatients:92%88[95%CI84-093]p <0001termsincreasedmostlyageadditionCONCLUSIONS:alsomayoutcome50At-riskCommunity-acquiredComorbiditiesElderlyHigh-riskLong-termNonagenariansPneumococcalPrognosticfactorsSevere

Similar Articles

Cited By